Home›Compare›InsideTracker vs Pallas Health

InsideTracker vs Pallas Health: Which Is Better?

Head-to-head comparison of InsideTracker and Pallas Health based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Pallas Health scores higher overall in our independent evaluation (65.7/100 vs 58.4/100), leading on value, product range. InsideTracker comes out ahead on experience, reputation. InsideTracker has the lower entry price (from $12/mo vs $60/mo), so the better value depends on which treatment you need.

Biomarker-analytics platform selling Quest-drawn blood panels plus an annual membership that turns results into nutrition, supplement and lifestyle recommendations; no prescribing.

Visit InsideTracker

Pallas Health is a July 2026-launched telehealth platform offering compounded and branded GLP-1s, longevity peptides, women's HRT, ED and prescription skincare, with unusually detailed compliance disclosures.

Visit Pallas Health

Score Breakdown

DimensionInsideTrackerPallas Health
Overall Score58.4/10065.7/100 ✓
Trust & Safety30%66/10066/100
Value25%50/10070/100 ✓
Experience20%62/100 ✓58/100
Product Range15%50/10080/100 ✓
Reputation10%62/100 ✓48/100

At a Glance

Founded20092026
HeadquartersCambridge, MANewark, DE
Publicly tradedNoNo
Treatment categories26
Treatments listed212
Starting price$12/mo$60/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryInsideTrackerPallas Health
Longevity & Peptides$28–$113
Ultimate Blood Panel (member price, $340/test)
$139–$199
NAD+

InsideTracker

+Published pricing, with blood draws at Quest Diagnostics locations nationwide and a mobile-draw option
+Ultimate panel spans roughly 40-50 biomarkers across 10 healthspan categories with a longitudinal dashboard for repeat testing
+More than 15 years of operating history, with HSA/FSA eligibility via Truemed
−No clinician consults or prescriptions; results are informational and must be taken to one's own doctor for treatment
−Mandatory $149/year auto-renewing membership on top of per-test fees; quarterly Ultimate testing runs roughly $1,500/year
−Trustpilot complaints cite unexpected renewal charges and legacy lifetime-access users being pushed into the paid membership
Read the full InsideTracker review →

Pallas Health

+Detailed clinical-disclosure page names the operating entity, provider network (Lion MD), dispensing pharmacies and state-by-state visit rules
+Prices published for every product, including branded options (Wegovy pill, Foundayo, pens at cash rates)
+Broad catalog for a new entrant: compounded and branded GLP-1s, NAD+, sermorelin, glutathione, women's HRT, ED and prescription skincare
−Launched July 2026 with no public patient reviews, so service quality is unproven
−Billed every 4 weeks (13 charges a year); the $239 semaglutide renewal is well above the $139 first month
−A real-time video visit is required in 7 states plus DC, which adds friction for those patients
Read the full Pallas Health review →

InsideTracker vs Pallas Health — FAQ

Is InsideTracker better than Pallas Health?

▾

Pallas Health scores higher overall in our independent evaluation (65.7/100 vs 58.4/100), leading on value, product range. InsideTracker comes out ahead on experience, reputation. InsideTracker has the lower entry price (from $12/mo vs $60/mo), so the better value depends on which treatment you need.

Is InsideTracker or Pallas Health cheaper?

▾

InsideTracker has the lower starting price (from $12/mo vs $60/mo for Pallas Health). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do InsideTracker and Pallas Health both offer?

▾

Both platforms treat Longevity & Peptides. InsideTracker covers 2 treatment categories total and Pallas Health covers 6.

Still deciding?